Slideshow
Author(s):
Migraine is the second leading cause of disability worldwide. New data show the number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades.
Combination of Migraine and Gestational Diabetes Poses Greater Risk for Premature Major Adverse Cardiovascular and Cerebrovascular Events
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
NeurologyLive® Brain Games: October 27, 2024
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
Clinical Utility of Middle Meningeal Artery Embolization as an Adjunctive Treatment of Subdural Hematoma
Discontinuation Patterns Provide Support for Long-Term Effectiveness of Erenumab